CACNA1G and cardiac hypertrophy: Cav3.2 may provide Ca2+ signal for cardiac hypertrophy [20] while Cav3.1 mediated Ca2+ influx is antihypertrophic via the NO/cGMP/PKG signaling pathway [21].